321 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

301130

Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd
CN¥23.92-0.3%-13.9%CN¥1.9bn/aPE34xn/a1.1%

688098

Shanghai Shen Lian Biomedical
CN¥4.47-1.3%-38.9%CN¥1.8bn/aPE136.6xn/a0.8%

952

Hubei Guangji Pharmaceutical
CN¥5.14-2.3%-36.5%CN¥1.8bn/aPS2.3xn/a0%

300519

Zhejiang Xinguang Pharmaceutical
CN¥11.25-0.2%-29.7%CN¥1.8bn/aPE31.7xn/a3.6%

603079

Zhejiang Shengda Bio-Pharm
CN¥10.360.7%-21.1%CN¥1.8bn/aPS2.4xn/a0.6%

301065

Zhejiang Benli Technology
CN¥16.600.5%-20.2%CN¥1.7bn/aPE26.9xn/a0.6%

688265

Shanghai Model Organisms Center
CN¥21.831.4%-45.9%CN¥1.7bn/aPS4.6xn/a0.6%

300871

Hvsen Biotechnology
CN¥10.18-2.0%-39.3%CN¥1.7bn/aPS1.7xE60.4%2.7%

600272

Shanghai Kai Kai Industry
CN¥8.900.2%-0.1%CN¥1.7bn/aPE41xn/a0.6%

300086

Honz Pharmaceutical
CN¥3.690.5%-38.9%CN¥1.7bn/aPS2.5xn/a0%

688670

Jiangsu Gdk Biological Technology
CN¥13.29-4.0%-73.6%CN¥1.6bn/aPS49xE102.4%0%

2898

Sailong Pharmaceutical GroupLtd
CN¥9.143.2%-15.5%CN¥1.6bn/aPE202.1xn/a0.2%

2370

Zhejiang Yatai Pharmaceutical
CN¥2.63-2.6%-35.9%CN¥1.6bn/aPS3.9xn/a0%

688189

Hunan Nucien Pharmaceutical
CN¥5.762.9%-40.6%CN¥1.6bn/aPS2.9xn/a0%

2826

Tibet AIM Pharm
CN¥8.17-2.2%-23.6%CN¥1.5bn/aPE43.7xn/a0.4%

688656

HOB Biotech GroupLtd
CN¥22.20-1.1%-35.8%CN¥1.4bn/aPE30.6xn/a1.8%

590

Tus-Pharmaceutical Group
CN¥5.64-1.1%-32.7%CN¥1.4bn/aPE130.1xn/a0%

688163

Shanghai Serum Bio-Technology
CN¥12.231.2%-44.6%CN¥1.3bn/aPE35.5xn/a1.6%

301075

Tibet Duo Rui Pharmaceutical
CN¥16.330.2%-31.2%CN¥1.3bn/aPE68.9xn/a0.8%

603139

Shaanxi Kanghui Pharmaceutical
CN¥12.852.5%-18.0%CN¥1.3bn/aPS1.9xn/a0%

688217

Shanghai Rightongene Biotechnology
CN¥22.152.3%-44.0%CN¥1.2bn/aPE172.5xE27.6%0.8%

600381

Qinghai Spring Medicinal Resources Technology
CN¥2.06-0.5%-74.7%CN¥1.2bn/aPS5xn/an/a

300030

Improve Medical Instruments
CN¥3.890.3%-47.6%CN¥1.2bn/aPS1.9xn/a0%

603716

Thalys Medical Technology Group
CN¥6.07-0.3%-37.4%CN¥1.1bn/aPB1xn/a0%
Page 13 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.